Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Nasolacrimal duct cyst describes a unilateral or bilateral congenital cyst of the nasolacrimal duct, which is almost always associated with dacryocystocele, presenting most commonly at birth or a few weeks of age (but rarely presenting in adulthood) as a benign, grayish blue mass in the inferomedial canthus or in the nasal cavity, that can cause epiphora, dacryocystitis (inflammation of the lacrimal sac) and nasal obstruction. It is more commonly reported in females.
Features include common findings: Nasolacrimal duct obstruction, Dacryocystitis, Nasal congestion, and Epiphora and others; and sometimes findings: Amblyopia, Fever, Poor suck, and Recurrent infections and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 4 | Amblyopia, Chronic irritative conjunctivitis, Corneal astigmatism |
Biomarker and diagnostic research for nasolacrimal duct cyst has been reported in the published literature.
Phenotype severity distribution: 8 common features.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for nasolacrimal duct cyst.
21 publications have been identified in PubMed for nasolacrimal duct cyst. Research spans Case Report / Case Series (52%), Review / Meta-Analysis (19%), and Diagnostic / Biomarker (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 11 | 52% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 4:32 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Lungs and breathing
2 |
Paroxysmal dyspnea, Episodic respiratory distress |
Metabolism | 1 | Fever |
Blood and immune system | 1 | Recurrent infections |
4 |
19% |
Testing and diagnosis research | 2 | 10% |
Disease patterns and progression | 2 | 10% |
Other research | 1 | 5% |
Clinical study results | 1 | 5% |
Sesana A (2026). [PMID: 38425127](https://pubmed.ncbi.nlm.nih.gov/38425127/). *Vet Ophthalmol*. [Case Report / Case Series]
Nagata J (2026). [PMID: 42105086](https://pubmed.ncbi.nlm.nih.gov/42105086/). *Graefes Arch Clin Exp Ophthalmol*. [Diagnostic / Biomarker]
Ren Y (2026). [PMID: 41686368](https://pubmed.ncbi.nlm.nih.gov/41686368/). *Ophthalmol Ther*. [Epidemiology / Natural History]
Thompson J (2025). [PMID: 38783093](https://pubmed.ncbi.nlm.nih.gov/38783093/). *Vet Ophthalmol*. [Case Report / Case Series]
Bothra N (2025). [PMID: 38775226](https://pubmed.ncbi.nlm.nih.gov/38775226/). *Semin Ophthalmol*. [Review / Meta-Analysis]
Sáenz Araya D (2025). [PMID: 40984927](https://pubmed.ncbi.nlm.nih.gov/40984927/). *Cureus*. [Review / Meta-Analysis]
Zulkiflee NR (2025). [PMID: 40093463](https://pubmed.ncbi.nlm.nih.gov/40093463/). *Indian J Otolaryngol Head Neck Surg*. [Case Report / Case Series]
Daga J (2025). [PMID: 39811416](https://pubmed.ncbi.nlm.nih.gov/39811416/). *Am J Ophthalmol Case Rep*. [Case Report / Case Series]
Banerjee P (2025). [PMID: 41971207](https://pubmed.ncbi.nlm.nih.gov/41971207/). *Rom J Ophthalmol*. [Case Report / Case Series]
Abumanhal M (2025). [PMID: 40696620](https://pubmed.ncbi.nlm.nih.gov/40696620/). *Medicine (Baltimore)*. [Case Report / Case Series]